DOCSLIB.ORG

Melbourne Biomedical Precinct Studley Rd to an Exceptional Network Economic and Investment Growth Swinburne University of of Skilled Workers, Quality for the State

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Melbourne Biomedical Precinct Studley Rd to an Exceptional Network Economic and Investment Growth Swinburne University of of Skilled Workers, Quality for the State The Royal Children’s Hospital + The Murdoch Children’s Research Institute The Royal Women’s Hospital Darwin Walter & Eliza Hall Institute Monash Institute of Pharmaceutical NT Science, Monash University + CSIRO QLD Royal Melbourne Hospital WA Brisbane C Florey Institute SA e m ete ry Rd The University of Melbourne NSW Perth Sydney A Precinct approach Victorian Comprehensive Cancer Centre Adelaide Royal Pde Canberra + Peter MacCallum Cancer Centre The Doherty Institute to collaboration Flemington Rd Elgin St St Vincent’s Hospital Melbourne Hobart Melbourne, Grattan St Swanston St Australia and innovation Arden St Curzon St Elizabeth St Lygon St La Trobe University Queensberry St d R g r e b Burgundy St Rathdowne St l Chetwynd St Victoria St e > id e Melbourne Brain Centre H r Peel St e Austin Health p Plan Melbourne, Victoria’s key metropolitan Franklin St p Melbourne has biomedical La Trobe St U Austin Hospital planning strategy, highlights the precincts Banksia St capabilities unparalleled in around Melbourne, Monash, Deakin, Olivia Newton-John Australia and amongst the and La Trobe universities as clusters CSL Cancer Wellness & world’s best. We are home which offer significant opportunities (Poplar Road) Research Centre for innovation as well as employment, Melbourne Biomedical Precinct Studley Rd to an exceptional network economic and investment growth Swinburne University of of skilled workers, quality for the state. Technology education providers, leading The Melbourne Biomedical Precinct Deakin University St Kilda Rd research institutes and a Partners are largely collocated to the Princes Hwy Commercial Rd Burwood & Geelong Campuses sophisticated health system. north of Melbourne’s CBD close to Monash University, Australia’s highest ranking university, Clayton � Caulfield There is a growing body of evidence the University of Melbourne. Punt Rd Campuses that shows the benefit of health precincts, The Precinct’s location means that High St Australian or clusters, to the economic and social it is well placed to add to and benefit Alfred Hospital prosperity of communities globally. & St Kilda Road Synchroton from the wealth of innovation happening Melbourne, the fastest growing city across Melbourne and Victoria. It is this CSIRO in Australia and the world’s most collaborative spirit across the state that will Manufacturing Blackburn Rd liveable, is no exception. Monash Flagship ensure that the biomedical sector remains Precinct Wellington Rd a cornerstone of Victoria’s economy. Alfred Health Princes Hwy Hudson Institute of Medical Research Cancer Clayton Rd Monash Children’s Council Victoria Hospital Burnet Institute Monash Medical Centre Baker IDI Heart & Diabetes Institute The Royal Children’s Hospital + The Murdoch Children’s Research Institute The Royal Women’s Hospital Darwin Walter & Eliza Hall Institute Monash Institute of Pharmaceutical NT Science, Monash University + CSIRO QLD Royal Melbourne Hospital WA Brisbane C Florey Institute SA e m ete ry Rd The University of Melbourne NSW Perth Sydney A Precinct approach Victorian Comprehensive Cancer Centre Adelaide Royal Pde Canberra + Peter MacCallum Cancer Centre The Doherty Institute to collaboration Flemington Rd Elgin St St Vincent’s Hospital Melbourne Hobart Melbourne, Grattan St Swanston St Australia and innovation Arden St Curzon St Elizabeth St Lygon St La Trobe University Queensberry St d R g r e b Burgundy St Rathdowne St l Chetwynd St Victoria St e > id e Melbourne Brain Centre H r Peel St e Austin Health p Plan Melbourne, Victoria’s key metropolitan Franklin St p Melbourne has biomedical La Trobe St U Austin Hospital planning strategy, highlights the precincts Banksia St capabilities unparalleled in around Melbourne, Monash, Deakin, Olivia Newton-John Australia and amongst the and La Trobe universities as clusters CSL Cancer Wellness & world’s best. We are home which offer significant opportunities (Poplar Road) Research Centre for innovation as well as employment, Melbourne Biomedical Precinct Studley Rd to an exceptional network economic and investment growth Swinburne University of of skilled workers, quality for the state. Technology education providers, leading The Melbourne Biomedical Precinct Deakin University St Kilda Rd research institutes and a Partners are largely collocated to the Princes Hwy Commercial Rd Burwood & Geelong Campuses sophisticated health system. north of Melbourne’s CBD close to Monash University, Australia’s highest ranking university, Clayton � Caulfield There is a growing body of evidence the University of Melbourne. Punt Rd Campuses that shows the benefit of health precincts, The Precinct’s location means that High St Australian or clusters, to the economic and social it is well placed to add to and benefit Alfred Hospital prosperity of communities globally. & St Kilda Road Synchroton from the wealth of innovation happening Melbourne, the fastest growing city across Melbourne and Victoria. It is this CSIRO in Australia and the world’s most collaborative spirit across the state that will Manufacturing Blackburn Rd liveable, is no exception. Monash Flagship ensure that the biomedical sector remains Precinct Wellington Rd a cornerstone of Victoria’s economy. Alfred Health Princes Hwy Hudson Institute of Medical Research Cancer Clayton Rd Monash Children’s Council Victoria Hospital Burnet Institute Monash Medical Centre Baker IDI Heart & Diabetes Institute The Melbourne Biomedical The Precinct Precinct Office Partners The Melbourne Biomedical Its establishment is the result of key The Office collaborates with a range of The Melbourne Biomedical The organisations are largely collocated Together the Precinct recommendations from the Premier’s stakeholders across three main areas: to the north of Melbourne’s CBD in the Partners employ around Precinct Office was established Jobs and Investment Panel. In its 2016 Precinct, through its 30 geographical area extending from East by the Victorian state report to the Victorian Government, the Strategic planning Precinct Partners, delivers Melbourne, Carlton and North Melbourne Panel’s message was clear in identifying The Office is developing a strategic to Parkville in the north. The Precinct also 28,000 government in late 2016 plan to identify and prioritise actions outstanding clinical care to drive economic development the Melbourne Biomedical Precinct as and education, and has strong connections with the Arden offering significant potential for job creation for the state and Precinct Partners over and Macaulay urban renewal precincts. people in the Precinct and strengthen and growth and increased investment, the next 20 years to maximise the produces world-class The close proximity of the Precinct both locally and internationally. potential of the Precinct. including its position as a world leader biomedical research. Partners has been key to building in biomedical research, The Executive Chair leads a small Advisory a culture of collaboration over many development and innovation. team of advisors and project managers, The Office plays an advisory role to We excel particularly in child and years (see list and map over page). 10,000 experienced in public sector and government and agencies, the Precinct adolescent health, cancer, mental Together the Precinct Partners employ health strategy development, policy Partners and staff, as well as investors health and neurosciences, infectious around 28,000 people, including 10,000 and planning. Ultimately the team’s and biomedical organisations locally diseases, and healthy ageing. Both researchers researchers, and contribute around A$3.6 role is to drive better health and economic and globally. individually and collectively these organisations are globally recognised billion to Victoria’s gross regional product. outcomes. It does this in the context of Promotion existing Victorian Government policies for their innovation and outstanding The Office promotes the Precinct The impact of the Precinct goes and strategies. patient outcomes. The precinct contributes as a great opportunity for research beyond geographical boundaries with collaboration, investment They include the big hospitals, collaborations and impact extending and employment. universities and research institutes that to other universities, hospitals and research have fundamentally improved patient organisations locally and globally. A$3.6 billion outcomes in Australia and internationally. to Victoria’s gross regional product. The Melbourne Biomedical The Precinct Precinct Office Partners The Melbourne Biomedical Its establishment is the result of key The Office collaborates with a range of The Melbourne Biomedical The organisations are largely collocated Together the Precinct recommendations from the Premier’s stakeholders across three main areas: to the north of Melbourne’s CBD in the Partners employ around Precinct Office was established Jobs and Investment Panel. In its 2016 Precinct, through its 30 geographical area extending from East by the Victorian state report to the Victorian Government, the Strategic planning Precinct Partners, delivers Melbourne, Carlton and North Melbourne Panel’s message was clear in identifying The Office is developing a strategic to Parkville in the north. The Precinct also 28,000 government in late 2016 plan to identify and prioritise actions outstanding clinical care to drive economic development the Melbourne Biomedical Precinct as and education, and has strong connections with the Arden offering significant potential for job creation for the state and Precinct
Load more

Recommended publications
  • Seizure Dynamics
    Balson et al. BMC Neuroscience 2014, 15(Suppl 1):P152 http://www.biomedcentral.com/1471-2202/15/S1/P152 POSTERPRESENTATION Open Access Seizure dynamics: a computational model based approach demonstrating variability in seizure mechanisms Richard S Balson1,2,3,4*, Dean R Freestone1,2,3, Mark J Cook2,3, Anthony N Burkitt1,2,4, David B Grayden1,2,4 From The Twenty Third Annual Computational Neuroscience Meeting: CNS*2014 Québec City, Canada. 26-31 July 2014 Epilepsy is a neurological disorder that affects approxi- animals, based upon recorded LFP 150 seconds prior to mately 1% of the world’s population. At present, the and post seizure, as well as during the seizure. The esti- underlying mechanisms involved in seizure generation mation results show that, for three of the four animals, and termination are not fully understood. A computa- the mechanisms involved in their seizures are similar. tional model-based approach to provide further insights For the fourth animal, the estimated physiology prior to, into physiological changes occurring in the brain prior during, and post seizure vary drastically. When compar- to, during, and post seizure is presented. We demon- ing the physiological dynamics between animals, we strate that an unscented Kalman filter [1] can be used found that the estimation results predicted that there to fit physiological parameters of a neural mass model are different mechanisms involved in seizure initiation, [2] to recorded EEG. This technique elucidates physiolo- evolution, and termination in each animal. The common gical changes in recorded EEG that cannot be deter- element in all the results, except for a single estimated mined with standard EEG analysis methods.
    [Show full text]
  • Low Resolution
    Australian Biochemist The Magazine of the Australian Society for Biochemistry and Molecular Biology Inc. August 2019, Volume 50, Number 2 VOLISSN 50 NO 2 AUGUST 1443-0193 2019 AUSTRALIAN BIOCHEMIST PAGE 1 Be inspired during the 3- da y progra m including a fa nta stic lineup of industry lea ding interna tiona l plena ry spea kers, a nd hea r from our society specia lty lectures, be enga ged with poster presenta tions a nd lea rn a t the E/MCR mini- symposium. For more informa tion on our spea kers, progra m a nd to register, visit our website www.a sbmb2019.com.a u REGISTER NOW! PAGE 2 AUSTRALIAN BIOCHEMIST VOL 50 NO 2 AUGUST 2019 Table of Contents 4 Editorial Committee 5 Editorial 7 Publications with Impact Distinct Mechanisms Govern Recognition of Viral and Host Ligands by an Innate Immune Receptor Buying Time for Contractile Signaling Genetic Stutters, Gut Feelings and Neurodegenerative Disease 11 Off the Beaten Track Why it Sometimes Pays to Work for Money 14 ASBMB Education Feature Glycogen Builder: the Game Making a Drama Out of Biochemistry From the Whiteboard to the Conference: Scaffolding Conference-style Poster Presentations 18 SDS Page The Importance of Blue Sky Research 19 Competition: Unscramble 20 ASBMB 2019 International Plenary Speaker Profiles 22 ASBMB 2019 Symposium Speakers 23 Melbourne Protein Group: an ASBMB Special Interest Group 24 ASBMB Shimadzu Education Award Report 26 Intellectual Property Patenting Inventions in the Microbiome Space 29 Queen’s Birthday Honours for ASBMB Members 31 ASBMB Awards 2020 33 Election of Council 2020 33 Annual General Meeting of ASBMB 34 New ASBMB Members 35 Forthcoming Meetings 36 Our Sustaining Members 41 ASBMB Council 42 Directory Front Cover Bachelor of Biomedicine students from the University of Melbourne participating in an acting skills workshop with Rinske Ginsberg, VCA Theatre, as part of the Performing Sciences program, where students devise short performances embodying biochemical concepts.
    [Show full text]
  • Menzies School of Health Research
    MENZIES SCHOOL OF HEALTH RESEARCH 2020-21 Pre-Budget Submission September 2020 Contact: Professor Alan Cass Director, Menzies School of Health Research Ph: 08 8946 8600 Email: [email protected] Web: www.menzies.edu.au ABN: 70 413 542 847 Menzies School of Health Research (Menzies) is pleased to put forward its 2020-21 Pre-Budget submission. 1. Summary of recommendations The medical and health research sector has an important role in supporting economic growth, job creation and attracting investment to Australia. This role has been further emphasised in key policy statements from both the Northern Territory and Commonwealth Governments to ensure the future prosperity of northern Australia. For example, medical and health research is a stated economic priority in the Northern Territory Economic Development Framework and its Economic Reconstruction Priorities, as well as being highlighted as a strategic priority in the Commonwealth’s White Paper on Developing Northern Australia. Directly related to supporting medical and health research in northern Australia, this pre-budget submission requests that the Commonwealth provide $5m to support a four (4) year extension to the Northern Australia Tropical Disease Collaborative Research Program (NATDCRP), administered by Menzies School of Health Research in collaboration with seven (7) of Australia’s leading health research organisations – James Cook University, Telethon Kids Institute, Burnet Institute, The University of Sydney, the South Australian Health and Medical Research Institute, Doherty Institute and QIMR Berghofer Medical Research Institute. The NATDCRP – now referred to as the HOT North Program - was announced as a $6.8m budget measure by the Minister for Trade and Investment, the Hon Andrew Robb on 10 May 2015.
    [Show full text]
  • Metropolitan Melbourne Public Hospitals Hospitals Current As at 19 July 2006 Sunbury Private
    The Northern Hospital Healesville & District Hospital Broadmeadows Health Service Bundoora Extended Care Centre Heidelberg Repatriation Hospital Austin Hospital and Sunshine Hospital Mercy Hospital for Women Royal Melbourne Hospital, Royal Park Western Hospital RCH Royal Talbot Rehablilitation Centre Tweedle Child & Family Health Centre RMH RWH Caritas Dental HS St George's Health Service Maroondah Hospital St Vincent's RVEEH Box Hill Hospital Peter MacCallum O'Connell Family Centre (Grey Sisters) Inc. The Alfred The Peter James Centre Williamstown Hospital Mercy Werribee Caulfield General Medical Centre Calvary Health Care Bethlehem Ltd Angliss Hospital Monash Medical Centre, Moorabbin Monash Medical Centre, Clayton Hampton Rehabilitation Hospital Sandringham & District Hospital Kingston Centre Queen Elizabeth Centre Dandenong Hospital Casey Hospital Royal Children's Hospital Dental Health Services Victoria Royal Melbourne Hospital Royal Women's Hospital Cranbourne Integrated Care Centre St Vincent's Hospital Caritas Christi Hospice Royal Victorian Eye & Ear Hospital Peter MacCallum Cancer Centre INSETINSET Frankston Hospital 0 500 1000 Metres Mt Eliza Rehabilitation, Aged and Palliative Care 01020 Kilometres Rosebud Hospital Metropolitan Melbourne public hospitals Hospitals current as at 19 July 2006 Sunbury Private Northpark Private Hospital Gambro Diamond Valley Clinic Victorian Rehabilitation Centre - Northern Melbourne Reservoir Private Hospital Essendon Private Hospital Victoria Warringal Private Hospital John Fawkner Private Hospital
    [Show full text]
  • 2016 Researchfest Abstracts
    POSTER CUTTING EDGE RESEARCH SESSIONS RESEARCH LECTURES Poster Opening Consumer Engagement Research Week Physiotherapy Education Precinct Awards Oral Presentations; Research Event L4 Austin Tower Education lecture theatre Sustainability; health Education lecture theatre Tues 4 Oct 17.00–18.00 L4 Austin Tower and the environment L4 Austin Tower Tue 4 Oct 14:00–15:00 Education lecture theatre Tue 4 Oct 16:00–17:00 Poster Exhibition L4 Austin Tower Education Precinct 3D Med Symposium Wed 19 Oct 14:00–16:00 Research Week Debate L4 Austin Tower Education lecture theatre John Lindell lecture theatre Mon 3 Oct to Fri 7 Oct L4 Austin Tower Research Week L4 Austin Tower Thu 5 Oct 14:00–18:00 Oral Presentations Thu 13 Oct 12:30–13:30 Poster Author Sessions Education lecture theatre Rooms 4.4 & 4.5 Quality projects L4 Austin Tower Research Week Education Precinct Nursing Forum Wed 26 Oct 10:00–12:00 Plenary Session L4 Austin Tower Education lecture theatre Professor Tim Flannery Tue 4 Oct 14:30–15:30 L4 Austin Tower Dunlop Medical Research John Lindell lecture theatre Thu 6 Oct 14:30–15:30 Thu 6 Oct 14:00–15:00 Foundation Symposium L4 Austin Tower John Lindell lecture theatre Wed 19 Oct 12:30–13:30 RJ Pierce Symposium L4 Austin Tower Education lecture theatre Wed 26 Oct 12:15–13:30 OCTOBER L4 Austin Tower Fri 14 Oct 11:00–13:00 M T W Th F TH Research Week 3 4 5 6 7 Oral presentations 10 11 12 13 14 John Lindell lecture theatre RESEARCHº L4 Austin Tower OCTOBER 2016 17 18 19 20 21 Tue 18 Oct 10:00–12:00 24 25 26 27 28 FEST 31 AMRF Young Investigator
    [Show full text]
  • Improving Outcomes of Deep Brain Stimulation for Essential Tremor with Motion Tracking and Speech Analysis
    IETF Grant Proposal: 27 February 2015 Improving Outcomes of Deep Brain Stimulation for Essential Tremor with Motion Tracking and Speech Analysis Brief Summary Deep Brain Stimulation (DBS) is a common form of treatment for medically refractory essential tremor (ET). DBS consists of one or two small electrode arrays that are placed in specific brain targets by a trained neurosurgeon. Controlled electrical pulses are then sent to these electrodes by a neuro- stimulator to modify brain activity and provide therapeutic benefit. The characteristics (duration, amplitude, and frequency) of these pulses must be set to minimize tremor, yet prevent unwanted side- effects such as speech difficulties. Usually, these parameters are set by a neurologist based on their observation of tremor and side-effect. In general, the ventral intermediate nucleus (VIM) of the brain is considered the most appropriate target for stimulation. Recently, however, the posterior subthalamic area (PSA) was also discovered to be an effective stimulation target. Since this discovery, much debate has ensued regarding which is the better target in terms of tremor and side-effect reduction. For each target, the stimulation level must also be considered due to influence on implant battery life. In this study we aim to determine which of the two targets provides the best outcome to the patient using novel methods to quantify tremor and side- effect. The majority of clinical assessments of ET rely on clinical scores based on observation. These are subjective measures influenced by the clinician’s opinion and experience. Unfortunately, the accuracy and sensitivity of such measures can be inadequate. To improve assessment of ET, we have developed our own method of tremor measurement based on electronic motion tracking.
    [Show full text]
  • The Royal Melbourne Hospital: Embarking on a Digital Journey with an ECM System
    Photo by WalkingMelbourne The Royal Melbourne Hospital: Embarking on a Digital Journey With an ECM System hen a specialty cancer hospital became part of the Parkville precinct that included the Royal Melbourne Hospital, leaders wanted to implement a common electronic medical Wrecord (EMR) system, a move that would enable the provider organisations to tap into the benefits associated with operating in a digital environment. ‘We wanted to have all the information and patient records electronically available for the clinicians at the cancer hospital when it opened up’, said Rhonda Carroll, former Director of Information and Performance at the Victoria, Australia-based facility. Unfortunately, though, the Victorian government did not fund the EMR initiative at the time. Leaders, however, did not let this setback deflate their efforts. Instead, they decided to take it upon themselves to keep their digital journey moving forward. Even without the EMR funding, the organisation could strive to eliminate as much paper as possible, connect standalone electronic clinical databases, and position the hospital to be ready to move to a fully featured EMR in the future. Produced in partnership with While the hospital had made quite a bit of information electronic, it wasn’t realising the myriad benefits typically associated with digitalisation. More strategic digitalisation While the opening of the cancer centre provided additional motivation, the hospital had already been on the path toward digitalisation for a few years. Indeed, in an effort to eliminate paper, various departments―including pathology, radiology, cardiology, emergency, and others ― had implemented electronic clinical databases. The problem: These systems all stood alone in silos, incapable of communicating with one another.
    [Show full text]
  • Pfcerli1 Is a Conserved Rhoptry Associated Protein Essential for Plasmodium Falciparum Merozoite Invasion of Erythrocytes
    ARTICLE https://doi.org/10.1038/s41467-020-15127-w OPEN PfCERLI1 is a conserved rhoptry associated protein essential for Plasmodium falciparum merozoite invasion of erythrocytes Benjamin Liffner 1,8, Sonja Frölich 1,8, Gary K. Heinemann2, Boyin Liu3, Stuart A. Ralph 3, ✉ Matthew W.A. Dixon 3, Tim-Wolf Gilberger4,5,6 & Danny W. Wilson 1,7 1234567890():,; The disease-causing blood-stage of the Plasmodium falciparum lifecycle begins with invasion of human erythrocytes by merozoites. Many vaccine candidates with key roles in binding to the erythrocyte surface and entry are secreted from the large bulb-like rhoptry organelles at the apical tip of the merozoite. Here we identify an essential role for the conserved protein P. falciparum Cytosolically Exposed Rhoptry Leaflet Interacting protein 1 (PfCERLI1) in rhoptry function. We show that PfCERLI1 localises to the cytosolic face of the rhoptry bulb membrane and knockdown of PfCERLI1 inhibits merozoite invasion. While schizogony and merozoite organelle biogenesis appear normal, biochemical techniques and semi-quantitative super- resolution microscopy show that PfCERLI1 knockdown prevents secretion of key rhoptry antigens that coordinate merozoite invasion. PfCERLI1 is a rhoptry associated protein iden- tified to have a direct role in function of this essential merozoite invasion organelle, which has broader implications for understanding apicomplexan invasion biology. 1 Research Centre for Infectious Diseases, School of Biological Sciences, University of Adelaide, Adelaide, SA 5005, Australia. 2 Experimental Therapeutics Laboratory, School of Pharmacy and Medical Sciences, University of South Australia Cancer Research Institute, Adelaide, SA 5005, Australia. 3 Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, VIC 3010, Australia.
    [Show full text]
  • 2010-2011 Annual Report
    Annual Report 2010-2011 Mastery of disease through discovery | www.wehi.edu.au Contents 1 About the institute 3 Director’s and Chairman’s report 5 Discovery 8 Cancer and Haematology 10 Stem Cells and Cancer 12 Molecular Genetics of Cancer 14 Chemical Biology 16 Molecular Medicine 18 Structural Biology 20 Bioinformatics 22 Infection and Immunity 24 Immunology The Walter and Eliza Hall Institute 26 Autoimmunity and Transplantation of Medical Research 28 Cell Signalling and Cell Death 1G Royal Parade 30 Inflammation Parkville Victoria 3052 Australia Telephone: (+61 3) 9345 2555 32 Molecular Immunology Facsimile: (+61 3) 9347 0852 34 Publications WEHI Biotechnology Centre 36 Awards 4 Research Avenue 37 Translation La Trobe R&D Park Bundoora Victoria 3086 Australia Translating our research 38 Telephone: (+61 3) 9345 2200 40 Developing our research Facsimile: (+61 3) 9345 2211 42 Patents www.wehi.edu.au www.facebook.com/WEHIresearch 43 Education www.twitter.com/WEHI_research 46 2010-11 graduates ABN 12 004 251 423 47 Seminars Acknowledgements 48 Institute awards Produced by the institute’s Community Relations department 49 Engagement Managing editor: Penny Fannin Editor: Liz Williams 51 Strategic partners Writers: Liz Williams, Vanessa Solomon and Julie Tester 52 Scientific and medical community Design and production: Simon Taplin Photography: Czesia Markiewicz and Cameron Wells 54 Public engagement 57 Engagement with schools Cover image 58 Donor and bequestor engagement Art in Science finalist 2010 Vessel webs 59 Sustainability Dr Leigh Coultas, Cancer and Haematology division 60 The Board This image shows the delicate intricacy in the developing eye of a transient population of web-like blood vessels.
    [Show full text]
  • Survey of Commercial Outcomes from Public Research (Scopr) 2019 Report
    techtransfer.org.au SURVEY OF COMMERCIAL OUTCOMES FROM PUBLIC RESEARCH (SCOPR) 2019 REPORT Survey and report delivered by FOREWORD There is an ever-present imperative to capture the commercial value of our research endeavour for our future wellbeing. To do so strategically, decision makers from laboratory, institutional and government levels need insights into how the research sector is currently engaging with industry to transfer knowledge and innovation, and thereby deliver benefits to our society from the fruits of our research. For many years in Australia there has been a focus on improving innovation metrics, thus I am delighted to acknowledge the initiative of gemaker and Knowledge Commercialisation Australasia (KCA) in producing the inaugural Survey of Commercial Outcomes from Public Research (SCOPR). The SCOPR takes its lead from the National Survey of Research Commercialisation (NSRC) produced since 2000 by the Department of Industry, Science, Energy and Resources. To avoid duplication, the Department has decided to cease the NSRC and will work with KCA to share knowledge, and access data collected by SCOPR. As we face the COVID-19 pandemic, effective knowledge transfer is more important than ever, so I hope that this report will spur our research institutions to even greater achievements. Realising effective knowledge transfer will depend on having skilled commercialisation professionals who can help researchers turn great ideas into beneficial products and services. I applaud KCA’s support for technology transfer professionals
    [Show full text]
  • Human DECR1 Is an Androgen-Repressed Survival Factor
    RESEARCH ARTICLE Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis Zeyad D Nassar1,2†, Chui Yan Mah1,2†, Jonas Dehairs3, Ingrid JG Burvenich4, Swati Irani1,2, Margaret M Centenera1,2, Madison Helm1,2, Raj K Shrestha5, Max Moldovan2, Anthony S Don6, Jeff Holst7, Andrew M Scott4, Lisa G Horvath8, David J Lynn2,9, Luke A Selth1,5,9, Andrew J Hoy10, Johannes V Swinnen3, Lisa M Butler1,2* 1University of Adelaide Medical School and Freemasons Foundation Centre for Men’s Health, University of Adelaide, Adelaide, Australia; 2South Australian Health and Medical Research Institute, Adelaide, Australia; 3KU Leuven- University of Leuven, LKI- Leuven Cancer Institute, Department of Oncology, Laboratory of Lipid Metabolism and Cancer, Leuven, Belgium; 4Tumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Melbourne, Australia; 5Dame Roma Mitchell Cancer Research Laboratories, University of Adelaide, Adelaide, Australia; 6NHMRC Clinical Trials Centre, and Centenary Institute, The University of Sydney, Camperdown, Australia; 7Translational Cancer Metabolism Laboratory, School of Medical Sciences and Prince of Wales Clinical School, UNSW Sydney, Sydney, Australia; 8Garvan Institute of Medical Research, NSW 2010; University of Sydney, NSW 2006; and University of New South Wales, Darlinghurst, Australia; 9College of Medicine and Public Health, Flinders University, Bedford Park, Australia; 10Discipline of Physiology, School of *For correspondence: Medical Sciences, Charles Perkins Centre, Faculty of Medicine and Health, The [email protected] University of Sydney, Camperdown, Australia †These authors contributed equally to this work Competing interests: The b authors declare that no Abstract Fatty acid -oxidation (FAO) is the main bioenergetic pathway in human prostate competing interests exist.
    [Show full text]
  • 2.6 Oceania 145 2.6 OCEANIA
    Regional Overview 2.6 Oceania 145 2.6 OCEANIA AUSTRALIA FIJI KIRIBATI MARSHALL ISLANDS MICRONESIA, FEDERATED STATES OF NAURU NEW ZEALAND PALAU PAPUA NEW GUINEA SAMOA SOLOMON ISLANDS TIMOR LESTE TONGA TUVALU VANUATU 146 Global State of Harm Reduction 2020 TABLE 2.6.1: Epidemiology of HIV and viral hepatitis, and harm reduction responses in Oceania Country/ People who HIV Hepatitis C Hepatitis B Harm reduction response territory with inject drugs prevalence (anti-HCV) (anti-HBsAg) reported among prevalence prevalence injecting drug people who among among 1 Peer use inject drugs people who people who 2 3 4 (%) inject drugs inject drugs NSP OAT distribution DCRs (%) (%) of naloxone (2,940)7 Australia 75,1785[2] 2.3[3] 45[4] 4.0[5] (4,182)6[2] [7,8] 2 (B,M)[6] Federated States nk nk nk nk x x x x of Micronesia Fiji nk nk nk nk x x x x Kiribati nk nk nk nk x x x x Marshall Islands nk nk nk nk x x x x New Zealand 18,0008[10] 0.2[10] 589[10] nk (185)10[11] (B,M)[11,12] 11[9] x Palau nk nk nk nk x x x x Papua New nk nk nk nk x x x x Guinea Samoa nk nk nk nk x x x x Solomon Islands nk nk nk nk x x x x Timor Leste nk nk nk nk x x x x Tonga nk nk nk nk x x x x Vanuatu nk nk nk nk x x x x nk = not known 1 Countries with reported injecting drug use according to Larney et al 2017.
    [Show full text]